Qingchang Meng

Title: Qingchang Meng: Innovator in Biopharmaceuticals

Introduction

Qingchang Meng is a notable inventor based in Georgetown, CA. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of compounds that target specific receptors in the human body. With a total of 3 patents to his name, Meng's work is recognized for its potential therapeutic applications.

Latest Patents

Among his latest patents, Meng has developed 5-cyclo indole compounds. These compounds are selective for a 5-HT_1D-like receptor and have a general formula that includes a six-membered, non-aromatic, optionally substituted carbocycle and a six-membered, non-aromatic, optionally substituted heterocycle. Additionally, he has worked on 5-alkyl indole compounds, which are also selective for the 5-HT_1D-like receptor, featuring a linear or branched lower alkyl group.

Career Highlights

Qingchang Meng is currently associated with Allelix Biopharmaceuticals Inc., where he continues to innovate and contribute to the field. His work is characterized by a focus on developing compounds that can lead to advancements in medical treatments.

Collaborations

Meng has collaborated with several professionals in his field, including Abdelmalik Slassi and Sumanas Rakhit. These collaborations have likely enhanced the scope and impact of his research.

Conclusion

Qingchang Meng is a prominent figure in the biopharmaceutical industry, with a strong portfolio of patents that reflect his innovative spirit. His contributions are paving the way for future advancements in therapeutic compounds.